Dr Antoine Hollebecque

Spécialité

Oncologue médical, expert colon, estomac, foie et pancréas

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

• Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC Registry. (1 avr. 2025)
• Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients. (1 mars 2025)
• New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe. (19 févr. 2025)
• Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer. (6 févr. 2025)
• Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases. (1 nov. 2024)